Biomarkers: Technologies and Global Markets
商品番号 : SMB-71350
| 出版社 | BCC Research |
| 出版年月 | 2025年1月 |
| ページ数 | 165 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,650 |
| 種別 | 英文調査報告書 |
Report Highlights
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
バイオマーカーの世界市場は、2023 年に 637 億ドルと評価されています。この市場は、2024 年から 2029 年までの年間平均成長率 (CAGR) 13.1% で、2024 年の 705 億ドルから 2029 年末までに 1,302 億ドルに成長すると予想されています。
Summary:
The market is driven by technological advances, the growing prevalence of chronic diseases such as cancer and cardiovascular conditions, rising demand for personalized medicine, investments in R&D, the expansion of biomarker applications in drug discovery, diagnostics and clinical trials, and government initiatives supporting healthcare innovation.
Report Scope:
The scope of this report on the global market for biomarker technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, technology, therapeutic area and end user. The report breaks down the market into several product categories: instruments, consumables (such as reagents, kits and panels), services and software. It also segments the market by technology: genomics, proteomics, metabolomics, imaging and bioinformatics. It also examines the biomarker market across the therapeutic areas of cancer; cardiovascular, metabolic, infectious and neurodegenerative diseases; and autoimmune disorders. The end-user segments are academic institutions, pharmaceutical and biotechnology companies, clinical research organizations, hospitals and diagnostic centers.
By region, the analysis encompasses North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The report also includes profiles of leading companies and highlights industry trends, major products, mergers and acquisitions, and other collaborations or partnerships.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||||||
| Base year market size | $63.7 Billion | ||||||||||||||||||||
| Market size forecast | $130.2 Billion | ||||||||||||||||||||
| Growth rate | CAGR of 13.1% from 2024 to 2029 | ||||||||||||||||||||
| Units considered | $ Billions | ||||||||||||||||||||
| Segments covered | By Product Type, Technology, Therapeutic Area, End User, and Region | ||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and the Rest of the World (RoW) | ||||||||||||||||||||
| Key Market Drivers |
| ||||||||||||||||||||
| Companies studied |
| ||||||||||||||||||||
Report Includes:
– 34 data tables and 62 additional tables
– An up-to-date overview of the global markets and technologies for biomarkers
– Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
– Evaluation of the size and revenue growth prospects, accompanied by a market share analysis by product type, technology, therapeutic area, end user, and region
– Assessment of market dynamics such as drivers, restraints and opportunities
– Coverage of major types of biomarkers and their use in clinical trial assessment, drug discovery and development, and therapeutics
– Review of patents issued for biomarker technologies and deep dive of patent data by year, technology type, application, company, assignee and applicant country
– A discussion on ESG challenges and practices in the industry
– Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews
– Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
– Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., and Agilent Technologies Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Classification of Biomarkers
Examples of Biomarkers
Susceptibility/Risk Biomarkers
Diagnostic Biomarkers
Monitoring Biomarkers
Prognostic Biomarkers
Predictive Biomarkers
Pharmacodynamic (Response) Biomarkers
Safety Biomarkers
Surrogate Biomarkers/Endpoints
Discovery, Verification and Validation
Biomarker Qualification
Applications of Biomarkers
Diagnostics, Therapeutics and Disease Monitoring
Drug Discovery and Development
Clinical Trials
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Diseases
Advances in Omics and Imaging Technologies
Market Restraints
High Development Costs
Requirement for Skilled Labor
Market Opportunities
Emerging Markets
Personalized Medicine
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
Genomics
Proteomics
Metabolomics
Imaging
Bioinformatics
Clinical Trials
Clinical Trial Analysis, by Therapeutic Area
Clinical Trial Analysis, by Study Status
Clinical Trial Analysis, by Study Type
Patent Analysis
Chapter 5 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
Biomarkers: Global Markets
Market Analysis by Product Type
Consumables
Instruments
Services
Software
Market Analysis by Technology
Proteomics
Genomics
Imaging
Bioinformatics
Metabolomics
Market Analysis by Therapeutic Area
Cancer
Cardiovascular and Metabolic Diseases
Neurodegenerative Diseases
Infectious Diseases
Autoimmune Diseases
Other Diseases
Market Analysis by End User
Hospitals and Diagnostic Labs
Academic and Research Institutes
Pharmaceutical and Biotech Companies
Contract Research Organizations
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Ranking of Companies in the Biomarker Industry
Chapter 7 Sustainability in Biomarkers Technologies and Global Markets: An ESG Perspective
Sustainability in the Biomarker Market
ESG Risks and Ratings: Understanding the Data
BCC Research Viewpoint
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BAYER AG
BD
BIO-RAD LABORATORIES INC.
BRUKER
DANAHER CORP.
- HOFFMANN-LA ROCHE LTD.
FUJIFILM HOLDINGS CORP.
GE HEALTHCARE
ILLUMINA INC.
JEOL LTD.
KONINKLIJKE PHILIPS N.V.
PROMEGA CORP.
QIAGEN
REVVITY
SHIMADZU CORP.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table A : Global Market for Biomarkers, by Product Type, Through 2029
Summary Table B : Global Market for Biomarkers, by Region, Through 2029
Table 1 : Categories of Biomarkers
Table 2 : Examples of Biomarkers
Table 3 : Clinical Trials in Biomarkers, by Therapeutic Area, 2021–2024*
Table 4 : Clinical Trials in Biomarkers, by Study Status, 2021–2024*
Table 5 : Clinical Trials in Biomarkers, by Type of Study, 2021–2024*
Table 6 : Patents Issued for Biomarkers, 2021–2024*
Table 7 : Patents Issued for Biomarkers, by Applicant, 2021–2024*
Table 8 : Global Market for Biomarkers, Through 2029
Table 9 : Global Market for Biomarkers, by Product Type, Through 2029
Table 10 : Global Market for Biomarkers, by Technology, Through 2029
Table 11 : Global Market for Biomarkers, by Therapeutic Area, Through 2029
Table 12 : Global Market for Biomarkers, by End User, Through 2029
Table 13 : Global Market for Biomarkers, by Region, Through 2029
Table 14 : North American Market for Biomarkers, by Country, Through 2029
Table 15 : European Market for Biomarkers, by Country, Through 2029
Table 16 : Asia-Pacific Market for Biomarkers, by Country, Through 2029
Table 17 : RoW Market for Biomarkers, by Sub-region, Through 2029
Table 18 : Market Rankings of Leading Companies in the Biomarker Industry, 2023
Table 19 : ESG Rankings for Major Biomarker Companies, 2024*
Table 20 : Information Sources in This Report
Table 21 : Abbreviations Used in This Report
Table 22 : Abbott: Company Snapshot
Table 23 : Abbott: Financial Performance, FY 2022 and 2023
Table 24 : Abbott: Product Portfolio
Table 25 : Abbott: News/Key Developments, 2023–2024
Table 26 : Agilent Technologies Inc.: Company Snapshot
Table 27 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 28 : Agilent Technologies Inc.: Product Portfolio
Table 29 : Agilent Technologies Inc.: News/Key Developments, 2023–2024
Table 30 : Bayer AG: Company Snapshot
Table 31 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 32 : Bayer AG: Product Portfolio
Table 33 : Bayer AG: News/Key Developments, 2022–2024
Table 34 : BD: Company Snapshot
Table 35 : BD: Financial Performance, FY 2022 and 2023
Table 36 : BD: Product Portfolio
Table 37 : BD: News/Key Developments, 2024
Table 38 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 39 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 40 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 41 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 42 : Bruker: Company Snapshot
Table 43 : Bruker: Financial Performance, FY 2022 and 2023
Table 44 : Bruker: Product Portfolio
Table 45 : Bruker: News/Key Developments, 2023
Table 46 : Danaher Corp.: Company Snapshot
Table 47 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 48 : Danaher Corp.: Product Portfolio
Table 49 : Danaher Corp.: News/Key Developments, 2022-2024
Table 50 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 51 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 52 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 53 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023
Table 54 : Fujifilm Holdings Corp.: Company Snapshot
Table 55 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 56 : Fujifilm Holdings Corp.: Product Portfolio
Table 57 : GE Healthcare: Company Snapshot
Table 58 : GE Healthcare: Financial Performance, FY 2022 and 2023
Table 59 : GE Healthcare: Product Portfolio
Table 60 : GE Healthcare: News/Key Developments, 2024
Table 61 : Illumina Inc.: Company Snapshot
Table 62 : Illumina: Financial Performance, FY 2022 and 2023
Table 63 : Illumina: Product Portfolio
Table 64 : Illumina Inc.: News/Key Developments, 2024
Table 65 : JEOL Ltd.: Company Snapshot
Table 66 : JEOL Ltd.: Financial Performance, FY 2022 and 2023
Table 67 : JEOL Ltd.: Product Portfolio
Table 68 : JEOL Ltd.: News/Key Developments, 2023
Table 69 : Koninklijke Philips N.V.: Company Snapshot
Table 70 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 71 : Koninklijke Philips N.V.: Product Portfolio
Table 72 : Koninklijke Philips N.V.: News/Key Developments, 2022 and 2023
Table 73 : Promega Corp.: Company Snapshot
Table 74 : Promega Corp.: Product Portfolio
Table 75 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 76 : Qiagen: Company Snapshot
Table 77 : Qiagen: Financial Performance, FY 2022 and 2023
Table 78 : Qiagen: Product Portfolio
Table 79 : Qiagen: News/Key Developments, 2023
Table 80 : Revvity: Company Snapshot
Table 81 : Revvity: Financial Performance, FY 2022 and 2023
Table 82 : Revvity: Product Portfolio
Table 83 : Revvity: News/Key Developments, 2022 and 2023
Table 84 : Shimadzu Corp.: Company Snapshot
Table 85 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 86 : Shimadzu Corp.: Product Portfolio
Table 87 : Shimadzu Corp.: News/Key Developments, 2023
Table 88 : Siemens Healthineers AG: Company Snapshot
Table 89 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 90 : Siemens Healthineers AG: Product Portfolio
Table 91 : Siemens Healthineers AG: News/Key Developments, 2024
Table 92 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 93 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 94 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 95 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure A : Global Market for Biomarkers, by Product Type, 2021–2029
Summary Figure B : Global Market for Biomarkers, by Product Type, 2021–2029
Figure 1 : Snapshot of the Market Dynamics of Biomarkers
Figure 2 : Share of Global Market for Biomarkers, by Product Type, 2023
Figure 3 : Share of Global Market for Biomarkers, by Technology, 2023
Figure 4 : Share of Global Market for Biomarkers, by Therapeutic Area, 2023
Figure 5 : Share of Global Market for Biomarkers, by End User, 2023
Figure 6 : Share of Global Market for Biomarkers, by Region, 2023
Figure 7 : Share of North American Market for Biomarkers, by Country, 2023
Figure 8 : Share of European Market for Biomarkers, by Country, 2023
Figure 9 : Share of Asia-Pacific Market for Biomarkers, by Country, 2023
Figure 10 : Share of RoW Market for Biomarkers, by Sub-region, 2023
Figure 11 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 14 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 15 : Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 16 : Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : BD: Revenue Share, by Country/Region, FY 2023
Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 22 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 27 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 28 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29 : GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 30 : GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 31 : Illumina: Revenue Share, by Business Unit, FY 2023
Figure 32 : Illumina: Revenue Share, by Country/Region, FY 2023
Figure 33 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 34 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 35 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
Figure 36 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
Figure 37 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 38 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 39 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 40 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 41 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 42 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
Figure 44 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
Figure 45 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
- 免疫療法薬の世界市場 2025-11-12
- 農業におけるAIの世界市場 2025-11-10
- 固体酸化物形燃料電池の技術と世界市場 2025-11-07
- 世界の電気アーク炉市場 2025-11-07
